This topic contains a solution. Click here to go to the answer

Author Question: What percentage of mechanical ventilated patients has a tracheostomy tube place at some point? a. ... (Read 8 times)

hbsimmons88

  • Hero Member
  • *****
  • Posts: 526
What percentage of mechanical ventilated patients has a tracheostomy tube place at some point?
 
  a. 5 to 10
  b. 10 to 15
  c. 20 to 25
  d. 30 to 35

Question 2

Which of the following are specific clinical objectives of ventilatory support?
 
  a. To reverse hypoxemia
  b. To prevent or reverse atelectasis
  c. To prevent sedation and neuromuscular blockade
  d. To reverse acute respiratory acidosis
  a. 1 and 3 only
  b. 1, 2, and 4 only
  c. 2 and 4 only
  d. 1, 2, 3, and 4



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lgoldst9

  • Sr. Member
  • ****
  • Posts: 372
Answer to Question 1

ANS: A
Approximately 5 to 10 of patients receiving mechanical ventilation have a tracheotomy per-formed at some point.

Answer to Question 2

ANS: B
The specific clinical objectives of ventilatory support are listed in Box 48-2.




hbsimmons88

  • Member
  • Posts: 526
Reply 2 on: Jul 16, 2018
Great answer, keep it coming :)


okolip

  • Member
  • Posts: 362
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

For a complete list of videos, visit our video library